Provided by Tiger Fintech (Singapore) Pte. Ltd.

60 degrees pharmaceuticals, Inc.

1.89
+0.14008.00%
Post-market: 1.80-0.0900-4.76%18:11 EDT
Volume:25.64K
Turnover:46.67K
Market Cap:2.78M
PE:-0.06
High:1.91
Open:1.74
Low:1.71
Close:1.75
Loading ...

60 Degrees Pharma Announces Closing of $1.043 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
31 Jan

60 Degrees Pharmaceuticals Inc - Announces Direct Offering of 1,021,549 Shares

THOMSON REUTERS
·
29 Jan

60 Degrees Pharma Announces $1.043 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
29 Jan

60 Degrees Pharma Announces $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire
·
29 Jan

60 Degrees Pharmaceuticals Gets Investigational Review Board Approval for Babesiosis Phase 2 Study

MT Newswires Live
·
28 Jan

60 Degrees Pharma Announces Irb Approval of Phase Ii Study to Evaluate Tafenoquine for Chronic Babesiosis

THOMSON REUTERS
·
28 Jan

60 Degrees Pharma Announces IRB Approval of Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis

GlobeNewswire
·
28 Jan

H.C. Wainwright Remains a Hold on 60 Degrees Pharmaceuticals, Inc. (SXTP)

TIPRANKS
·
08 Jan

BRIEF-60 Degrees Pharmaceuticals Enrolls First Patient In Tafenoquine Expanded Access Clinical Study

Reuters
·
08 Jan

60 Degrees Pharmaceuticals enrolls first patient in tafenoquine study

TIPRANKS
·
08 Jan

60 Degrees Pharmaceuticals Enrolls First Patient in Tafenoquine Expanded Access Clinical Study for Persistent (B. Microti) Babesiosis

THOMSON REUTERS
·
08 Jan

60 Degrees Pharmaceuticals Enrolls First Patient in Tafenoquine Expanded Access Clinical Study for Persistent (B. microti) Babesiosis

GlobeNewswire
·
08 Jan

Analysts Offer Insights on Healthcare Companies: 60 Degrees Pharmaceuticals, Inc. (SXTP), Ionis Pharmaceuticals (IONS) and Zura Bio (ZURA)

TIPRANKS
·
25 Dec 2024

H.C. Wainwright Remains a Hold on 60 Degrees Pharmaceuticals, Inc. (SXTP)

TIPRANKS
·
24 Dec 2024

60 Degrees signs patent license deal with Tufts Medical, says H.C. Wainwright

TIPRANKS
·
24 Dec 2024

60 Degrees Pharmaceuticals, Tufts Medical Center Sign Patent License Deal Over Potential Babesiosis Treatment

MT Newswires Live
·
23 Dec 2024